Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine—Response

On Behalf of the S1609 Team

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)2434
Number of pages1
JournalClinical Cancer Research
Volume26
Issue number10
DOIs
StatePublished - May 15 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this